台股 » 個股 » 逸達 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

逸達

(6576)
  • 股價
    79.9
  • 漲跌
    ▼1.7
  • 漲幅
    -2.08%
  • 成交量
    220
  • 產業
    上櫃 生技醫療類股
  • 117人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
逸達 (6576)籌碼相關-華南永昌-鳳山 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-鳳山 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2026/07/1600.00581.0081.60-5185-2.69%
2026/07/15180.3000.0081.7011930.52%
2026/06/2900.00581.6081.30-5169-2.95%
2026/06/1800.001380.5078.40-13160-8.12%
2026/04/2700.00281.6081.50-2182-1.09%
2026/04/1400.00076.0077.0001670.00%
2026/04/0900.00076.7077.2001680.00%
2026/04/0800.00077.5077.5001680.00%
2026/04/0100.00075.9077.3001780.00%
2026/03/1900.00078.0078.0001810.00%
2026/03/18078.6300.0078.4001790.01%
2026/03/0400.000.179.7080.20-0.1177-0.06%
2026/02/050.186.1000.0086.600.12280.04%
2026/01/2700.00582.5082.80-5215-2.32%
2026/01/1500.00180.0080.00-1202-0.49%
2026/01/0900.00180.9080.80-1212-0.47%
2026/01/0700.00079.4079.7002120.00%
2025/12/31080.8000.0080.6002190.00%
2025/12/3000.00380.1080.50-3220-1.36%
2025/12/2600.00482.0082.00-4219-1.82%
2025/12/16080.8000.0080.6002190.00%
2025/12/0200.00180.2080.40-1270-0.37%
2025/11/2600.00073.0074.4002880.00%
2025/11/2100.00172.9074.00-1314-0.32%
2025/11/18174.30174.7076.3003090.00%
2025/11/17193.7000.0080.6013060.33%
2025/11/11077.2000.0076.4002590.00%
2025/11/10077.4000.0075.9002590.00%
2025/10/30078.3000.0078.5002770.00%
2025/09/2600.00182.5082.50-1253-0.39%
2025/09/2400.00383.2083.80-3251-1.19%
2025/09/1000.00284.5084.10-2232-0.86%
2025/09/05182.5000.0084.2012100.47%
2025/09/0200.00079.0080.0001920.00%
2025/09/01178.90279.8077.70-1189-0.53%
2025/08/29276.7000.0077.5021841.08%
2025/08/28179.8000.0080.0011750.57%
2025/08/26278.6000.0081.4021551.28%
2025/08/2500.00082.1081.7001400.00%
2025/08/22381.3000.0081.4031422.11%
2025/08/2100.00181.3081.90-1141-0.71%
2025/08/20182.2000.0082.0011400.71%
2025/08/1800.00177.5077.90-1128-0.78%
2025/08/0700.00178.8079.30-1122-0.82%
2025/08/06179.3000.0079.3011220.82%
2025/08/0500.00080.0079.7001220.00%
2025/08/0400.00076.0080.2001200.00%
2025/07/2200.00171.8072.10-1113-0.88%
2025/07/21174.2000.0073.8011100.91%
逸達SIF技術平台跨足中樞神經系統領域 兩項候選藥物明年進入人體臨床試驗Anue鉅亨-2026/05/22
逸達 相關文章
逸達 相關影音